Establishment Labs (ESTA) Revenue & Revenue Breakdown
Establishment Labs Revenue Highlights
Latest Revenue (Y)
$211.08M
Latest Revenue (Q)
$53.78M
Main Geography (Y)
EMEA
Establishment Labs Revenue by Period
Establishment Labs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $211.08M | 27.14% |
| 2024-12-31 | $166.03M | 0.53% |
| 2023-12-31 | $165.15M | 2.13% |
| 2022-12-31 | $161.70M | 27.64% |
| 2021-12-31 | $126.68M | 49.61% |
| 2020-12-31 | $84.68M | -5.46% |
| 2019-12-31 | $89.56M | 46.33% |
| 2018-12-31 | $61.21M | 76.49% |
| 2017-12-31 | $34.68M | 75.15% |
| 2016-12-31 | $19.80M | - |
Establishment Labs generated $211.08M in revenue during NA 2025, up 27.14% compared to the previous quarter, and up 249.27% compared to the same period a year ago.
Establishment Labs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $53.78M | 4.84% |
| 2025-06-30 | $51.30M | 23.98% |
| 2025-03-31 | $41.38M | -7.05% |
| 2024-12-31 | $44.51M | 10.66% |
| 2024-09-30 | $40.23M | -8.82% |
| 2024-06-30 | $44.12M | 18.70% |
| 2024-03-31 | $37.17M | 17.77% |
| 2023-12-31 | $31.56M | -18.04% |
| 2023-09-30 | $38.51M | -20.71% |
| 2023-06-30 | $48.56M | 4.38% |
| 2023-03-31 | $46.52M | 6.19% |
| 2022-12-31 | $43.81M | 14.56% |
| 2022-09-30 | $38.24M | -7.15% |
| 2022-06-30 | $41.19M | 7.12% |
| 2022-03-31 | $38.45M | 8.89% |
| 2021-12-31 | $35.31M | 21.61% |
| 2021-09-30 | $29.04M | -9.24% |
| 2021-06-30 | $31.99M | 5.47% |
| 2021-03-31 | $30.34M | 12.51% |
| 2020-12-31 | $26.96M | 18.48% |
| 2020-09-30 | $22.76M | 117.28% |
| 2020-06-30 | $10.47M | -57.22% |
| 2020-03-31 | $24.48M | 0.96% |
| 2019-12-31 | $24.25M | 6.10% |
| 2019-09-30 | $22.85M | 5.40% |
| 2019-06-30 | $21.68M | 4.36% |
| 2019-03-31 | $20.78M | 26.72% |
| 2018-12-31 | $16.40M | 0.68% |
| 2018-09-30 | $16.29M | 18.80% |
| 2018-06-30 | $13.71M | -7.47% |
| 2018-03-31 | $14.82M | 25.44% |
| 2017-12-31 | $11.81M | 61.26% |
| 2017-09-30 | $7.32M | -15.10% |
| 2017-06-30 | $8.63M | 24.69% |
| 2017-03-31 | $6.92M | - |
Establishment Labs generated $53.78M in revenue during Q3 2025, up 4.84% compared to the previous quarter, and up 121.91% compared to the same period a year ago.
Establishment Labs Revenue Breakdown
Establishment Labs Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Asia Pacific | $34.54M | $48.41M | $33.95M | - | - |
| EMEA | $91.05M | $78.21M | $80.15M | - | - |
| Latin America | $39.93M | $35.00M | $48.89M | $52.44M | $38.23M |
| North America | $45.56M | $4.41M | - | - | - |
| Other Geographical Areas | - | - | $2.16M | $994.00K | $865.00K |
| Asia Pacific And Middle East | - | - | - | $59.56M | $35.68M |
| Europe | - | - | - | $48.70M | $51.91M |
Latest
Establishment Labs's latest annual revenue breakdown by geography, as of Dec 25: EMEA (43.14%), North America (21.58%), Latin America (18.92%), and Asia Pacific (16.36%).
Quarterly Revenue by Country
| Country | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Latin America | $11.66M | $11.65M | $9.49M | $7.13M | $17.52M | $9.57M | $7.91M | $8.37M | $12.58M | $16.32M | $11.62M | $13.75M | $12.32M | $14.18M | $12.19M | $13.26M | $9.79M | $7.17M | $8.00M | $7.80M |
| Asia Pacific | $9.10M | $11.10M | $7.58M | $6.76M | $29.04M | $10.77M | $8.60M | $5.99M | $2.42M | $11.53M | $14.02M | - | - | - | - | - | - | - | - | - |
| North America | $17.33M | $11.88M | $10.25M | $6.09M | $4.09M | $318.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EMEA | $26.52M | $19.16M | $23.98M | $21.39M | $38.04M | $19.56M | $20.60M | $16.65M | $23.33M | $20.19M | $19.98M | - | - | - | - | - | - | - | - | - |
| Other Geographical Areas | - | - | - | - | - | - | $62.00K | $547.00K | $180.00K | $532.00K | $898.00K | $168.00K | $286.00K | $232.00K | $307.00K | $150.00K | - | $569.00K | $147.00K | $169.00K |
| Europe | - | - | - | - | - | - | - | - | - | - | - | $12.29M | $8.71M | $13.37M | $14.34M | $13.56M | $11.13M | $14.53M | $12.69M | $12.05M |
| Asia Pacific And Middle East | - | - | - | - | - | - | - | - | - | - | - | $17.61M | $16.92M | $13.41M | $11.62M | $8.34M | $8.12M | $9.73M | $9.49M | $6.94M |
Latest
Establishment Labs's latest quarterly revenue breakdown by geography, as of Dec 25: EMEA (41.04%), North America (26.83%), Latin America (18.04%), and Asia Pacific (14.09%).
Establishment Labs Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AHCO | AdaptHealth | $3.24B | $820.31M |
| TDOC | Teladoc Health | $2.53B | $626.44M |
| CNMD | CONMED | $1.37B | $337.93M |
| NVCR | NovoCure | $655.35M | $167.20M |
| UFPT | UFP | $602.80M | $154.56M |
| AZTA | Azenta | $593.82M | $148.64M |
| ESTA | Establishment Labs | $211.08M | $53.78M |
| SSII | SS Innovations | $42.48M | $12.83M |
| KMTS | KESTRA MEDICAL | $27.81M | $22.57M |
| SYRE | Spyre Therapeutics | - | - |
| ZYME | Zymeworks | $-27.11M | $48.73M |